Most recently, it's been determined that conolidine and the above derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in equivalent regions as classical opioid receptors, it binds to a big range of endogenous opioids. In contrast to most opioid receptors, this receptor acts to be a scavenger https://jamesf864npq5.bloggosite.com/profile